Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Ono’s Half-Year Operating Profit Up 25.1% on Double-Digit Drop in R&D, SGA Costs Amid COVID-19
October 30, 2020
- GSK Might Adjust Shipments for Cervarix as Surge in Demand Expected
October 29, 2020
- Sumitomo Dainippon’s Japan Sales Activities Hit by COVID-19, Virtual Calls Strengthened: President
October 29, 2020
- Sumitomo Dainippon’s Half-Year Sales Up 13.4% on Latuda Growth
October 29, 2020
- Santen Gets Asian Rights to Aerie’s Glaucoma Meds
October 29, 2020
- Enhertu Earns FDA’s Priority Tag for Gastric Cancer, Decision Due in Q1 2021
October 29, 2020
- AbbVie’s JAK Inhibitor Rinvoq Filed for Atopic Dermatitis in Japan
October 29, 2020
- Eisai Launches JV in China to Forge Health Service Platform for Elderly
October 29, 2020
- Copay Rose for Some Patients as Leuplin Issue Triggered Shortage of 6-Month Depot: HCPs
October 28, 2020
- 1st Patient Enrolled in Global COVID-19 Study for Eritoran, Apremilast
October 28, 2020
- Opdivo Plus Cabometyx Filed for RCC in Japan: Ono/Takeda
October 28, 2020
- Opdivo-Yervoy Pair Filed for Malignant Pleural Mesothelioma in Japan
October 28, 2020
- Eisai Snaps Up Worldwide Rights for All of Cogstatethe’s Cognitive Function Tests
October 28, 2020
- Takeda Files Japan NDA for Short Bowel Syndrome Drug
October 28, 2020
- Sumitomo Dainippon Links Up with US Health Tech for R&D on Blood Collection and Stabilization Device
October 28, 2020
- Pharma’s Half-Year Earnings Season in Full Swing from This Week
October 27, 2020
- Ono Says Honjo’s 22.6 billion Yen Claim Groundless, No Agreement Reached on 40% Opdivo Fee Proposal
October 27, 2020
- Medicago Inks COVID-19 Vaccine Deal with Canadian Govt
October 27, 2020
- NC-6004-Keytruda Combo Racks Up Positive US PIIa Results for Head and Neck Cancer: NanoCarrier
October 27, 2020
- CureApp Launches Prescription Platform for Therapeutic Apps
October 26, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…